Gene · 701
Papers3,969
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 3,969
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Biallelic MAD2L1BP (p31comet) mutation is associated with mosaic aneuploidy and juvenile granulosa cell tumors. | JCI Insight | 2023 | 37796616 | PubTator, text mining | PubMed |
| Characterization of an Mtbp Hypomorphic Allele in a Diethylnitrosamine-Induced Liver Carcinogenesis Model. | Cancers (Basel) | 2023 | 37760565 | PubTator, text mining | PubMed |
| TRIM6: An Upregulated Biomarker with Prognostic Significance and Immune Correlations in Gliomas. | Biomolecules | 2023 | 37759698 | PubTator, text mining | PubMed |
| Progerin, an Aberrant Spliced Form of Lamin A, Is a Potential Therapeutic Target for HGPS. | Cells | 2023 | 37759521 | PubTator, text mining | PubMed |
| Disclosing transcriptomics network-based signatures of glioma heterogeneity using sparse methods. | BioData Min | 2023 | 37752578 | PubTator, text mining | PubMed |
| METTL3 exerts synergistic effects on m6A methylation and histone modification to regulate the function of VGF in lung adenocarcinoma. | Clin Epigenetics | 2023 | 37742030 | PubTator, text mining | PubMed |
| Signaling protein abundance modulates the strength of the spindle assembly checkpoint. | Curr Biol | 2023 | 37738972 | PubTator, text mining | PubMed |
| A new vulnerability to BET inhibition due to enhanced autophagy in BRCA2 deficient pancreatic cancer. | Cell Death Dis | 2023 | 37735513 | PubTator, text mining | PubMed |
| A bifunctional kinase-phosphatase module balances mitotic checkpoint strength and kinetochore-microtubule attachment stability. | EMBO J | 2023 | 37712330 | PubTator, text mining | PubMed |
| Drug repurposing based on differentially expressed genes suggests drug combinations with possible synergistic effects in treatment of lung adenocarcinoma. | Cancer Biol Ther | 2023 | 37710391 | PubTator, text mining | PubMed |
| An Early Neoplasia Index (ENI10), Based on Molecular Identity of CD10 Cells and Associated Stemness Biomarkers, is a Predictor of Patient Outcome in Many Cancers. | Cancer Res Commun | 2023 | 37707389 | PubTator, text mining | PubMed |
| Inhibition of the serine/threonine kinase BUB1 reverses taxane resistance in prostate cancer. | iScience | 2023 | 37705955 | PubTator, text mining | PubMed |
| Ribonucleotide reductase regulatory subunit M2 (RRM2) as a potential sero-diagnostic biomarker in non-small cell lung cancer. | PLoS One | 2023 | 37699023 | PubTator, text mining | PubMed |
| The potential role of CDC20 in tumorigenesis, cancer progression and therapy: A narrative review. | Medicine (Baltimore) | 2023 | 37682144 | PubTator, text mining | PubMed |
| The mutational landscape of the adult healthy parous and nulliparous human breast. | Nat Commun | 2023 | 37673861 | PubTator, text mining | PubMed |
| CENP-E activation by Aurora A and B controls kinetochore fibrous corona disassembly. | Nat Commun | 2023 | 37658044 | PubTator, text mining | PubMed |
| Lysosome-related genes: A new prognostic marker for lung adenocarcinoma. | Medicine (Baltimore) | 2023 | 37657029 | PubTator, text mining | PubMed |
| Investigation of germline variants in Bahraini women with breast cancer using next-generation sequencing based-multigene panel. | PLoS One | 2023 | 37656691 | PubTator, text mining | PubMed |
| Histone H3 K27M-mediated regulation of cancer cell stemness and differentiation in diffuse midline glioma. | Neoplasia | 2023 | 37647805 | PubTator, text mining | PubMed |
| A co-formulation of interferons alpha2b and gamma distinctively targets cell cycle in the glioblastoma-derived cell line U-87MG. | BMC Cancer | 2023 | 37644431 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/701/papers?page=16